Cipla profit rises over 39 per cent to Rs1,081.49 crore
15 Jun 2010
Pharmaceutical major Cipla Ltd today reported a 39.22 per cent rise in its stand-alone after-tax profit, at Rs1081.49 crore for the year ended 31 March 2010, against Rs776.81 crore for the year ended 31 March 2009.
Total income of the company increased to Rs5,713.24 crore during the year ended 31 March 2010 from Rs5,315.82 crore in the year ended 31 March 2009, audited results showed.
Group profit (PAT) also increase by over 39 per cent to Rs1,082.59 crore during the year ended 31 March 2010 against Rs771.02 crore in the year ended 31 March 2009.
Total income of the group increased to Rs5,713.02 crore during the year ended 31 March 2010 from Rs5,315.09 crore in the year ended 31 March 2009.
The board of directors of the company at its meeting today, inter alia, recommended payment of dividend of Rs2 per equity share of Rs2 face value (100 per cent), amounting to Rs160.58 crore, for the year 2009-2010, the company said in a filing with the Bombay Stock Exchange (BSE).
To invest $56 million in 2 biotech companies
The Cipla board today approved investment to the tune of $56 million in 2 biotech companies having joint venture partner in China.